Obstructive sleep apnoea (OSA) is frequently associated with comorbidities that include
metabolic, cardiovascular, renal, pulmonary and neuropsychiatric. There is considerable …

Although commonly observed in clinical practice, the heterogeneity of obstructive sleep
apnoea (OSA) clinical presentation has not been formally characterised. This study was the …

Obstructive sleep apnea (OSA) is a common disorder, characterized by cyclic cessation of
airflow for 10 seconds or more. There is growing awareness that OSA is related to the …

Obstructive sleep apnoea (OSA) is a common disease, recognized as an independent risk
factor for a range of clinical conditions, such as hypertension, stroke, depression and …

Obstructive sleep apnoea (OSA), characterized by recurrent periods of upper airway
obstruction and intermittent hypoxaemia, is prevalent in patients with cardiovascular disease …

Obstructive sleep apnoea (OSA) leads to both acute and chronic physiological effects on the
cardiovascular system. There is now a large amount of evidence showing that OSA is …

Obstructive sleep apnea (OSA)-induced biological changes include intermittent hypoxia,
intermittent hypercapnia, intrathoracic pressure changes, sympathetic activation and sleep …

Obstructive sleep apnea (OSA) is a worldwide highly prevalent disease associated with
systemic consequences, including excessive sleepiness, impairment of neurocognitive …

Background Obstructive sleep apnoea (OSA) is a heterogeneous disorder, and improved
understanding of physiologic phenotypes and their clinical implications is needed. We …

Rationale There is a paucity of large cohort studies examining the association of obstructive
sleep apnoea (OSA) with clinical outcomes including all-cause mortality, coronary heart …